(Q46625994)

23 December 2017

title

Antitumor and antimetastatic actions of eicosapentaenoic acid ethylester and its by-products formed during accelerated stability testing (English)

1 reference

23 December 2017

author name string

Yoshiyuki Kimura

series ordinal

1

1 reference

23 December 2017

Maho Sumiyoshi

series ordinal

2

1 reference

23 December 2017

publication date

1 July 2005

1 reference

23 December 2017

published in

Cancer Science

1 reference

23 December 2017

volume

96

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

441-450

1 reference

23 December 2017

Fat, fish, fish oil and cancer

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

Tumor interactions with the vasculature: angiogenesis and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

The role of natural killer cells in immune surveillance of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

Cutting Edge: IL-10-producing CD4+ T cells mediate tumor rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

Antitumor and antimetastatic activity of IL-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

A cancer therapy resistant to resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00067.X

10.1111/J.1349-7006.2005.00067.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

16053516

1 reference

23 December 2017